These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1974191)

  • 1. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the O-demethylation processes.
    Mutlib AE; Nelson WL
    Drug Metab Dispos; 1990; 18(3):309-14. PubMed ID: 1974191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways of gallopamil metabolism. Regiochemistry and enantioselectivity of the N-dealkylation processes.
    Mutlib AE; Nelson WL
    Drug Metab Dispos; 1990; 18(3):331-7. PubMed ID: 1974195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
    Nelson WL; Olsen LD; Beitner DB; Pallow RJ
    Drug Metab Dispos; 1988; 16(2):184-8. PubMed ID: 2898330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regiochemistry and enantioselectivity in the oxidative N-dealkylation of verapamil.
    Nelson WL; Olsen LD
    Drug Metab Dispos; 1988; 16(6):834-41. PubMed ID: 2907462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and identification of the N-glucuronides of norgallopamil and norverapamil, unusual metabolites of gallopamil and verapamil.
    Mutlib AE; Nelson WL
    J Pharmacol Exp Ther; 1990 Feb; 252(2):593-9. PubMed ID: 2313589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the enantioselective oxidative metabolism of metoprolol by verapamil in human liver microsomes.
    Kim M; Shen DD; Eddy AC; Nelson WL; Roskos LK
    Drug Metab Dispos; 1993; 21(2):309-17. PubMed ID: 8097702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the calcium antagonist gallopamil in man.
    Weymann J; Bühler V; Hege HG; Müller-Peltzer H; Schenk G; Stieren B; Hollmann M
    Arzneimittelforschung; 1989 May; 39(5):605-7. PubMed ID: 2757679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites.
    Remmel RP; Crews BC; Kozak KR; Kalgutkar AS; Marnett LJ
    Drug Metab Dispos; 2004 Jan; 32(1):113-22. PubMed ID: 14709628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of substrate configuration on chlorpheniramine N-demethylation by hepatic microsomes from rats, rabbits, and mice.
    Thompson JA; Shioshita GW
    Drug Metab Dispos; 1981; 9(1):5-9. PubMed ID: 6111432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the antianxiety drug buspirone in the rat.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1989; 17(6):625-33. PubMed ID: 2575498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of aliphatic formamides: metabolites of (+-)-N-methyl-N-(1-methyl-3,3-diphenylpropyl) formamide in rats.
    Slatter JG; Mutlib AE; Abbott FS
    Biomed Environ Mass Spectrom; 1989 Sep; 18(9):690-701. PubMed ID: 2790257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6.
    Mautz DS; Nelson WL; Shen DD
    Drug Metab Dispos; 1995 Apr; 23(4):513-7. PubMed ID: 7600921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
    Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
    Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolism of the new cardiotonic agent denopamine (TA-064) by rat and rabbit liver preparations. Oxidation, methylation, and glucuronidation.
    Suzuki T; Hashimura Y; Takeyama S
    Drug Metab Dispos; 1985; 13(2):246-54. PubMed ID: 2859176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine.
    Kraemer T; Bickeboeller-Friedrich J; Maurer HH
    Drug Metab Dispos; 2000 Mar; 28(3):339-47. PubMed ID: 10681380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of alkenebenzene derivatives in the rat. II. Eugenol and isoeugenol methyl ethers.
    Solheim E; Scheline RR
    Xenobiotica; 1976 Mar; 6(3):137-50. PubMed ID: 1274378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.